Patient Guide: Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 50 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04029363
Status: 🟢 Enrolling Now
Condition: Mitral Regurgitation
Phase: NA

Where You Can Participate

This study is available at 50 locations across the country.

Top locations include:
  • • Darlinghurst, New South Wales
  • • Newcastle, New South Wales
  • • Sydney, New South Wales
  • • And 47 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk - Join Clinical Trial NCTNCT04029363

How to Join This Clinical Trial - NCTNCT04029363

Learn how to participate in this NA trial studying an investigational therapy for Mitral Regurgitation. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Mitral Regurgitation. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Mitral Regurgitation
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04029363 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: RECRUITING

Clinical Research Site

Newcastle, New South Wales 2305 - Australia

Status: RECRUITING

Clinical Research Site

Sydney, New South Wales 2109 - Australia

Status: WITHDRAWN

Clinical Research Site

Auchenflower, Queensland 4066 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, 5000 - Australia

Status: RECRUITING

Clinical Research Site

Brisbane, - Australia

Status: RECRUITING

Clinical Research Site

Heidelberg, 3084 - Australia

Status: TERMINATED

Clinical Research Site

Melbourne, 3004 - Australia

Status: RECRUITING

Clinical Research Site

Newcastle, - Australia

Status: RECRUITING

Clinical Research Site

Perth, 6150 - Australia

Status: RECRUITING

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Mitral Regurgitation:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships